Summary:
The purpose of this clinical research study is to learn more about the use of the study drug, IMC-1, for the potential treatment of fibromyalgia. IMC-1 is somewhat different from other investigational drugs in that it is a combination of two drugs that already have FDA approval for the treatment of other conditions, but not for fibromyalgia. The main purpose of this study is to see whether IMC-1 can help participants with fibromyalgia.
Qualified Participants Must:
• Participants must be between the ages of 18 and 65 and experiencing symptoms of fibromyalgia
Qualified Participants May Receive:
If you qualify, you may receive investigational medication and study-related procedures from a local doctor. Reimbursement for time and travel related to study participation may be provided.